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How	to	Take	Blood	
Pressure
• Hypertension	 is	called	the	“silent	killer”	because	it	has	no	warning	signs	or	 symptoms	(Centers	 for	Disease	Control	and	Prevention	[CDC],	 2014).
• In	 rare	cases,	HTN	can	cause	symptoms	like	headaches	or	vomiting	(CDC,	 2014).
• HTN	is	often	asymptomatic	and	may	remain	unrecognized	 if	at-risk	patients	are	not	 screened	(Klemas&	Dowling,	2015,	 p.	18).
• Blood	pressure	 (BP)	 is	the	major	indicator	of	essential	hypertension	(see	figure	1),	 so	it	is	important	 to	know	how	to	 take	blood	pressure.	
The	author	 chose	to	write	about	hypertension	because	she	takes	care	of	patients	and	 family	members	with	hypertension	on	a	 frequent	basis,	and	 is	likely	to	face	the	challenge	of	managing	patients	with	hypertension	 (HTN)	 in	her	future	role	as	a	nurse	practitioner	due	 to	the	high	prevalence	of	HTN	among	men	and	women.	Non-Hispanic	black	adults	have	the	highest	prevalence	(42.1%)	compared	with	white	(28.0%),	 Hispanic	(26.0%),	 and	Asian	Americans	(24.7%).	In	2010,	 high	blood	pressure	contributed	to	 the	death	of	more	 than	362,000	Americans.	Hypertension	 is	defined	as	a	systolic	blood	pressure	 (SBP)	of	140	mmHg	or	higher	and/or	 a	diastolic	blood	pressure	 (DBP)	of	90mmHg	 or	higher.	Hypertension	 is	often	referred	 to	as	a	“silent	killer”	because	many	people	with	the	disease	are	asymptomatic.	
• Wait	at	least	5	minutes	between	entry	 into	 the	office	and	blood	pressure	measurement	 (Siu,	2015,	 p.	779).
• Use	an	appropriately	 sized	arm	cuff,	and	placed	 the	patient's	arm	at	the	 level	of	the	right	atrium	during	 measurement	(Siu,	2015,	p.	779).
• Measure	blood	pressure	 in	both	arms	to	check	for	any	difference	at	least	once;	if	a	difference	is	noted	 then	any	subsequent	readings	should	be	 taken	 from	the	arm	with	the	higher	 reading	(Potts,	2014,	 p.	148).
• Understand	 that	systolic	blood	pressure	 is	the	pressure	 in	 the	artery	during	 systole	or	when	 the	heart	 is	contracting;	diastolic	blood	pressure	 is	the	pressure	 in	the	arteries	during	diastole	or	when	 the	heart	 is	relaxing	and	filling	with	blood	(Potts,	2014,	 p.	146).
• Multiple	measurements	over	 time	have	better	positive	predictive	value	for	hypertension	 than	a	single	measurement	(Siu,	2015,	 p.	779).
• In	addition	 to	office	blood	pressure	measurement,	ambulatory	blood	pressure	measurement	 (ABPM)	and	home	blood	pressure	measurement	(HBPM)	may	be	used	to	confirm	a	diagnosis	of	hypertension	after	initial	screening	(Siu,	2015,	 p.	780).
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Figure	1	 (Bostock-Cox,	2013,	 p.	532):	
Classification	of	blood	pressure	for	adults.
ConclusionNursing	Implications
According	to	Klemas and	Dowling	(2015,	 p.	18),	 the	 risk	factors	for	HTN	include:
• Diabetes.
• Advanced	age.
• Being	African	American.
• Smoking	 tobacco.
• Excess	alcohol	consumption.
• Sedentary	 lifestyle.	
• Consumption	 of	diet	high	 in	sodium	and	 low	in	potassium.
Risk Factors for
Hypertension
Pathophysiology	of	Essential	Hypertension	
(See	figure	2).
• The	pathogenesis	of	HTN	 is	multifactorial	and	develops	from	a	complex	interaction	of	genetic	and	environmental	 factors	(Majumder &	Wu,	2015,	 p.	258).
• Endothelial	dysfunction,	enhanced	activation	of	sympathetic	nervous	system	(CNS),	and	structural	abnormalities	in	resistance	vessels	play	critical	roles	in	 the	development	and	progression	of	HTN,	but	physiologically,	the	renin	angiotensin	system	(RAS)	is	one	of	the	 important	pathways	for	regulating	blood	pressure	and	vascular	tone	in	 the	human	body	 (Majumder&	Wu,	2015,	 p.	258).
• The	RAS	pathway	is	initiated	in	the	kidney	with	the	proteolytic	conversion	of	angiotensinogen	(produced	 in	 the	liver)	to	angiotensin	I	 (Ang I)	by	renin	(produced	 in	 the	kidney);	Ang I	 is	an	inactive	decapeptidewhich	can	be	converted	 into	a	vasoconstrictive	octapeptide,	Ang II,	by	the	action	of	angiotensin	converting	enzyme	(Majumder &	Wu,	2015,	 p.	258).
• Effects	of	Ang II	(Bostock-Cox,	2013,	 p.	534)	 include:	Increased	sympathetic	activity;	tubular	sodium	(Na+)	and	chloride	(Cl–)	 reabsorption	 and	potassium	(K+)	excretion	(water	 retention);	aldosterone	secretion	(increasing	water	[H2O]	retention);	arteriolar	vasoconstriction	(increase	in	blood	pressure),	 and	 increased	antidiuretic	hormone	 (ADH)	secretion	from	the	pituitary	gland	 (increasing	H20	absorption).
• The	actions	propagated	by	Ang II	result	in	an	increased	in	blood	pressure.
• Though	RAS	is	widespread	in	the	body,	 the	main	source	of	 renin	 is	the	juxtaglomerular	apparatus	of	the	kidney,	while	that	of	angiotensin	converting	enzyme	(ACE)	 is	abundantly	present	 [on]	cell	surface	of	endothelial	cells,	especially	in	the	lungs	(Majumder&	Wu,	2015,	 p.	259).
• The	major	stimuli	for	secretion	of	renin	 from	the	 juxtaglomerular	apparatus	include	glomerular	hypoperfusion,	 reduced	 sodium	intake,	and	 increased	activity	of	the	sympathetic	nervous	system	(Simões e	Silva	&	Flynn,	2012,	 p.	1836).
Figure	2:	Pathophysiology	 of	essential	hypertension.
• Initiation	of	medication	is	based	on	 the	level	of	HTN	and	 the	number	 of	 risk	factors	that	are	present	along	with	any	evidence	of	damage	 to	organs,	 such	as	the	heart	or	kidneys	(Potts,	2014,	 p.	147).
• Pathological	outcomes	induced	by	angiotensin	II	 include	myocardial	infarction	(MI),	heart	 failure,	 stroke,	and	renal	 failure	(Ferrari,	 2013,	 p.	3).
• HTN	is	the	second	 leading	cause	of	end-stage	renal	disease	(ESRD)	after	diabetes	(Mennuni et	al.,	2014,	 p.	74).
• Research	shows	salt	sensitivity	is	disproportionately	 manifest	in	African	Americans;	healthy	African	Americans	have	been	shown	 to	have	more,	 not	less,	activation	of	the	RAS	system	than	Whites;	circulating	aldosterone	levels	are	also	higher	 in	African	Americans	than	 in	Whites	(Flack,	Nasser,	&	Levy,	2011,	 p.	84).
• Understanding	 the	pathophysiology	will	aid	in	 the	initiation	of	pharmacological	therapy	 in	 the	management	of	HTN	(see	figure	3).
• In	people	under	 the	age	of	55,	 ACE	inhibitors—or	angiotensin	receptor	blockers	(ARBs)	if	ACE	 inhibitors	cause	coughing—are	used	as	first-line	drugs	(Bostock-Cox,	2013,	 p.	534).
• In	people	over	55,	 calcium-channel	blockers	(CCBs)	such	as	amlodipine	or	felodipine are	recommended	as	first-line	treatment	 (Bostock-Cox,	2013,	 p.	534).
• Untreated	HTN	leads	to	progressive	end-organ	damage	such	as	the	eye	(hypertensive	retinopathy),	 kidneys	(end-stage	renal	failure),	brain	 (cerebrovascular	accident),	and	heart	 (heart	 failure)	(Nadella	&	Howell,	2015,	p.	276).
• Understanding	 adverse	drug	 reactions	(ADRs)	can	lead	to	a	better	patient	outcome.	For	example,	ACE	 inhibitors	may	lead	to	an	increased	amount	 of	circulating	bradykinin,	 leading	to	coughing;	 if	this	happens,	angiotensin	receptor	blockers	(ARBs)	may	be	used,	as	these	do	not	affect	bradykinin	 levels	(Bostock-Cox,	2013,	p.	534).
• Measure	BP	and	ensure	 that	blood	pressure	 is	within	normal	 ranges,	educate	patients	 to	modify	behaviors	 related	to	diet,	physical	activity,	smoking,	weight	loss,	stress,	alcohol	consumption,	and	medication	compliance.
• The	currently	 recommended	dietary	strategies	to	lower	BP	include	reducing	salt	intake,	increasing	potassium	intake,	weight	loss,	moderation	of	alcohol	consumption,	and	adoption	 of	balanced	and	 “heart-friendly”	dietary	patterns,	 such	as	the	well-established	Dietary	Approaches	to	Stop	Hypertension	 (DASH)	diet	(Koliaki &	Katsilambros,	2013,	 p.	402)	 – See	figure	4.
• When	taking	BP,	nurses	need	 to	understand	 and	educate	patients	about	possible	short-term	 factors	that	may	affect	BP	readings	such	as	physical	activity,	drugs	(including	caffeine	and	nicotine),	pain,	 stress,	and	emotions	(Siu,	2015,	 p.	780).	
• Nurses	should	pay	close	attention	to	 “white	coat	syndrome”.	 Isolated	clinic	HTN	in	the	medical	setting	and	 in	the	presence	of	medical	personnel	 (known	as	"white	coat"	hypertension)	 is	well	documented	(Siu,	2015,	 p.	780).
• U.S.	Preventive	Services	Task	Force	(USPSTF)	recommends	confirmation	outside	of	the	clinical	setting	before	a	diagnosis	of	HTN	is	made	and	 treatment	is	started	 (Siu,	2015,	 p.	781).
• Given	the	higher	 incidence	of	HTN	in	populations	with	risk	factors,	annual	 screening	may	be	warranted	for	persons	aged	40	years	or	older,	African	Americans	of	any	age,	and	persons	who	are	overweight	or	obese	(Siu,	2015,	 p.	783).
The	diagnosis	of	HTN	is	complicated	by	the	 “white	coat”	phenomenon;	 therefore,	ABPM	and	HBPM	should	be	considered	before	a	definitive	diagnosis	is	made.	Though	pharmacological	treatment	is	key	to	lowering	BP	by	altering	peripheral	vascular	resistance	and	cardiac	output,	 a	holistic	approach	will	require	both	 the	use	of	pharmacological	intervention	and	lifestyle	modification.	Healthcare	providers	need	 to	work	 in	partnership	 with	their	patients	to	accomplish	set	goals.	Hypertension	often	 last	a	lifetime,	therefore,	keeping	BP	under	 control	 can	lower	the	risk	for	heart	disease,	stroke	and	kidney	 failure.
Figure	4:	DASH	food	pyramid.Figure	3	 (Bostock-Cox,	2013,	 p.	533).
